KDM6B and metabolic dysfunction-associated steatotic liver disease: FGF21 signal-induced phosphorylation of JMJD3 at a single residue, Thr-1044, may, thus, provide a highly specific therapeutic option for treatment of NAFLD and other diseases associated with autophagy dysfunction.